Brief: Inspira Announces 510(K) FDA Submission Of Inspira Art100 Towards Commercialization
13/09/2023 13:34
Sept 13 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ ANNOUNCES 510(K) FDA SUBMISSION OF INSPIRA™
ART100
TOWARDS COMMERCIALIZATION
* INSPIRA TECHNOLOGIES OXY BHN - ANNOUNCED HAD SUBMITTED
ITS
INSPIRA ART100 TO U.S FDA WITH POTENTIAL CLEARANCE EXPECTED
DURING FIRST HALF OF 2024
Source text for Eikon: ID:nPn2wCfkla
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM